BE study design issue [Design Issues]

posted by Dr_Dan  – 2019-12-18 15:04  – Posting: # 20992
Views: 753

Hi John
if the recommended dosage regimen of the IR as per product monograph IR is to be given every 4 hrs then this means that higher doses have either a safety issue or the dose/effect relationship is in disfavor of higher doses. In this case AUC alone does not matter. Consequently, a regulatory body will reject the study
Hope this helps
KR
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

Activity
 Admin contact
20,453 posts in 4,295 threads, 1,414 registered users;
online 26 (0 registered, 26 guests [including 19 identified bots]).
Forum time (Europe/Vienna): 21:38 CET

My dear, science is a cruel mistress.    Paul Shenar (as Dr. Laurence)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5